Quick observations on market developments, earnings releases, and investment opportunities as they emerge.
As we close out 2024, several themes have dominated the investment landscape: AI transformation, interest rate normalization, and the resilience of quality companies. Looking ahead to 2025, we see opportunities emerging in previously overlooked sectors...
Read MoreThe Federal Reserve cut rates by 25bps as widely expected, but the forward guidance suggests a more measured approach in 2025. This should benefit quality companies with strong balance sheets while potentially creating headwinds for highly leveraged names...
Read MoreQ4 earnings season is providing mixed signals across sectors. Technology continues to show resilience, while consumer discretionary faces margin pressure. Key takeaways from companies in our coverage universe...
Read MoreWhile growth stocks continue to capture headlines, several quality value plays are trading at attractive multiples. These companies offer strong cash generation and trading at discounts to intrinsic value despite solid fundamentals...
Read MoreAs we enter the holiday season, it's worth reflecting on what we're grateful for as investors: access to quality companies, transparent markets, and the compound power of patient capital allocation over time...
Read MoreThe ongoing rotation from growth to value continues to create opportunities for disciplined investors. We're seeing particularly attractive setups in industrials and select healthcare names that have been unfairly penalized...
Read MoreFollowing the election results, we're analyzing the potential policy implications for different sectors. While political outcomes create near-term volatility, our focus remains on company-specific fundamentals and long-term value creation...
Read MoreQ3 delivered solid returns across most of our key positions. The market's focus on quality companies with strong execution continues to vindicate our investment approach. Looking ahead, we see several catalysts developing...
Read More